Oncology Discovery Posts Optimizing for Luck in Drug Development Continue readingOptimizing for Luck in Drug Development Comments closed An Immuno-Oncology Target You’ve (Probably) Never Heard of – Releasing the Brakes on the Innate Immune System Continue readingAn Immuno-Oncology Target You’ve...
Discovery research is the first step in transforming innovative ideas into groundbreaking therapies. At its core are two key pillars: Chemistry and Biologics, are both essential for understanding diseases and developing effective treatments. With a world-class team, cutting-edge facilities, and a passi...
Immuno-oncology Drug Development Cell Viability and Immune Cell Activation Assays Solutions Across the Drug Discovery ContinuumFill out the form to download your copy of the Solutions for Therapeutic Discovery Brochure: First name* Last name* Professional email address* Country/Region* Organization name*...
Specialty: Genetics, OncologyInstitution: Gradalis, Inc.Address: 1700 Pacific Ave., Suite 1100, Dallas, Texas, 75201, United States Published on February 25, 2013 Abstract: Despite billions of dollars allocated to cancer research, cancer remains the number 2 cause of death in the United States...
Focus on oncology, inflammatory disease & neurobiology markers Ready-to-use panels & modules Scalable to 100+ biomarkers Explore PhenoCode Discovery Panels PhenoCode Signature Panels Designed for the ever-changing immunotherapy landscape High-plex targeted protein panels Core immuno-oncology markers Co...
Therapeutic areas of expertise include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, fibrotic diseases and more. To find out more, please visit www.sygnaturediscovery.com. The Protein Science department provides research services to clients globally. These ...
up from 2.0 million cases in 2024. This projects the need for drugs for cancer treatment. The need for innovative oncology drugs remains high, leading to a consistent demand for drug discovery in this therapeutic area. The acceleration of the drug development process offered through AI further ...
Science and Technology Technology Platforms Supporting Capabilities Partners Investors News Over 560 million yuan! PepLib has transferred a new preclinical drug candidate to Jiudian Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer ...
due to the significant investments made in oncology over the last 20 years, the widespread adoption of tumor profiling in research and the clinical setting, and the emergence of highly curated oncology real-world data sets. now, there is an opportunity for companies to take the lessons learned ...
The Drug Discovery Outsourcing Market is segmented by Type (Medical Chemistry Service, Biology Service), Drug Type (Small Molecule, Large Molecules (Biopharmaceuticals)), Therapeutic Area (Oncology, Infectious Disease, Respiratory Disease, Cardiovascular, Gastrointestinal, Others), and Geography (North ...